MedPath

Motivational Interviewing for Nurses' Smoking Cessation

Not Applicable
Completed
Conditions
Health Behavior
Health Personnel Attitude
Smoking Cessation
Interventions
Behavioral: Brief advice
Behavioral: Motivational interviewing for smoking cessation in nurses
Registration Number
NCT03219060
Lead Sponsor
Clinica Universidad de Navarra, Universidad de Navarra
Brief Summary

This study's objective was to test the efficacy, acceptability and feasibility of a motivational interviewing (MI) based smoking cessation intervention with nurses.

Detailed Description

Despite the important role that health professionals have in reducing tobacco use, many have a smoking habit themselves. The prevalence of smoking is particularly high among nurses. A smoking cessation intervention for nurses who smoked, based on MI, was designed and evaluated following the UK Medical Research Council's (MRC) framework for complex interventions.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Nurses who were smokers
  • Nurses willing to participate in the study
Exclusion Criteria
  • Nurses who were pregnant

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupBrief adviceBrief advice following 5As
Intervention groupMotivational interviewing for smoking cessation in nursesMI based four individual sessions
Primary Outcome Measures
NameTimeMethod
Biochemically verified smoking cessationFollowing nurses' self-report of quitting (end of intervention (1 month) to 3 month follow-up)

Urine sample collected in nurses who self-reported being abstinent for at least one week

Participant satisfactionEnd of intervention (1 month)

Client Satisfaction Questionnaire (CHQ-8) (Roberts et al 1984)

Duration of sessionsEnd of intervention (1 month)

Following researcher's diary records

Secondary Outcome Measures
NameTimeMethod
Changes in Mean cigarettes smokedBaseline, end of intervention (1 month) and 3 month follow-up

Number of cigarettes smoked

Changes in Stages of changeBaseline, end of intervention (1 month) and 3 month follow-up

Assessment of desire and readiness to quit smoking (Prochaska and Velicer, 1997)

Changes in Nicotine DependenceBaseline, end of intervention (1 month) and 3 month follow-up

Assessment of nicotine dependence using the Fagerström Test for Nicotine Dependence (FTND) (Becoña and Vazquez, 1998)

Changes in Self-efficacyBaseline, end of intervention (1 month) and 3 month follow-up

Assessment of general self-efficacy using GSE scale (Scholz et al, 2002)

Changes in Depression scoreBaseline, end of intervention (1 month) and 3 month follow-up

Depression screening using the Patient Health Questionnaire (PHQ-9) (Kroenke et al 2001)

Adherence to MIEnd of intervention (1 month)

Assessment of intervention fidelity and adherence to MI principles using Motivational Interviewing Treatment Integrity (MITI) Code (Moyers et al 2005)

Trial Locations

Locations (1)

Clinica Universidad de Navarra

🇪🇸

Pamplona, Navarra, Spain

© Copyright 2025. All Rights Reserved by MedPath